When the 13-year-old boy's doctor recommended the parents attend diabetes education, only the dad showed because the mom was ...

Baby bison appear to have a blast chasing each other at Yellowstone National Park ...

MIDDLETOWN, Pa. — A Dauphin County couple has been accused of medically neglecting a 13-year-old child in their care after ...

Dr Vinesh Padayachy highlights the alarming rise of carbapenem-resistant Enterobacterales, a serious threat to diabetic and ...

A Norwegian woman was detained by Immigration and Customs Enforcement during what was supposed to be a routine green card ...

Diabetes is one of the rapidly growing global diseases. According to the latest World Health Organization report released in ...

Sun Pharma has launched an eye-opening awareness push about a common—and commonly overlooked—complication of diabetes. | Sun Pharma has launched an eye-opening awareness push about a common—and ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

While headlines about 'Ozempic face' warn that the rapid weight loss associated with GLP-1 drugs can prematurely age people's ...

Now imagine swapping some of that hardware for medicated skin cream that never pokes your skin. That is the vision behind a new Nature study describing a polymer that can haul insulin straight through ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

The nods allow Regeneron to better compete with Roche, which stormed the market in 2022 with Vabysmo. The Swiss drugmaker's ...